{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:03:23Z","timestamp":1782414203810,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000993","name":"Battelle","doi-asserted-by":"publisher","award":["DE-AC05-76RL01830"],"award-info":[{"award-number":["DE-AC05-76RL01830"]}],"id":[{"id":"10.13039\/100000993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014732","name":"Neurofibromatosis Therapy Acceleration Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.crmeth.2024.100772","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:41:51Z","timestamp":1715596911000},"page":"100772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening"],"prefix":"10.1016","volume":"4","author":[{"given":"Huyen Thi Lam","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan E.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anela","family":"Tosevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al Shihabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton J.","family":"Tebon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny J.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Panossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.C.","family":"Gosline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-2885","authenticated-orcid":false,"given":"Alice","family":"Soragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2024.100772_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.crmeth.2024.100772_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.crmeth.2024.100772_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/515504","article-title":"Confirmation of a Double-Hit Model for the NF1Gene in Benign Neurofibromas","volume":"61","author":"Serra","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000126543","article-title":"NF1 Gene Structure and NF1 Genotype\/Phenotype Correlations","volume":"16","author":"Upadhyaya","year":"2008","journal-title":"Neurofibromatoses"},{"key":"10.1016\/j.crmeth.2024.100772_bib5","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3390\/cells9112365","article-title":"Neurofibromin Structure, Functions and Regulation","volume":"9","author":"Bergoug","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.crmeth.2024.100772_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","article-title":"The NF1 somatic mutational landscape in sporadic human cancers","volume":"11","author":"Philpott","year":"2017","journal-title":"Hum. Genom."},{"key":"10.1016\/j.crmeth.2024.100772_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajpath.2010.10.041","article-title":"The Development of Cutaneous Neurofibromas","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.crmeth.2024.100772_bib8","first-page":"i107","article-title":"Management of cutaneous neurofibroma: current therapy and future directions","volume":"2","author":"Chamseddin","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.crmeth.2024.100772_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13023-018-0772-z","article-title":"Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study","volume":"13","author":"Cannon","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.crmeth.2024.100772_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13023-019-1265-4","article-title":"Cutaneous neurofibromas: patients\u2019 medical burden, current management and therapeutic expectations: results from an online European patient community survey","volume":"14","author":"Guiraud","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.crmeth.2024.100772_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging genotype\u2013phenotype relationships in patients with large NF1 deletions","volume":"136","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib12","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype\u2013Phenotype Correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.crmeth.2024.100772_bib13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.0000000000005791","article-title":"Considerations for development of therapies for cutaneous neurofibroma","volume":"91","author":"Verma","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.crmeth.2024.100772_bib14","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","article-title":"Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1","volume":"18","author":"Sabbagh","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41416-018-0073-2","article-title":"Cutaneous neurofibromas in the genomics era: current understanding and open questions","volume":"118","author":"Allaway","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.crmeth.2024.100772_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.45","article-title":"A high-throughput molecular data resource for cutaneous neurofibromas","volume":"4","author":"Gosline","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.crmeth.2024.100772_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000517011","article-title":"Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1","volume":"238","author":"Kallionp\u00e4\u00e4","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.crmeth.2024.100772_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-020-01103-4","article-title":"Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing","volume":"9","author":"Brosseau","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.crmeth.2024.100772_bib19","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.crmeth.2024.100772_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11912-021-01032-y","article-title":"Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib","volume":"23","author":"Galvin","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.crmeth.2024.100772_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.crmeth.2024.100772_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2017.10.012","article-title":"Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening","volume":"299","author":"Kraniak","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.crmeth.2024.100772_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110385","article-title":"Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas","volume":"38","author":"Mazuelas","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.crmeth.2024.100772_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.106","article-title":"Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells","volume":"5","author":"Ferrer","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.crmeth.2024.100772_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41597-020-0508-5","article-title":"A clinically and genomically annotated nerve sheath tumor biospecimen repository","volume":"7","author":"Pollard","year":"2020","journal-title":"Sci. Data"},{"key":"10.1016\/j.crmeth.2024.100772_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139807","article-title":"Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins","volume":"131","author":"Mo","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.crmeth.2024.100772_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","article-title":"Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells","volume":"9","author":"Radomska","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.crmeth.2024.100772_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120402","article-title":"A porcine model of neurofibromatosis type 1 that mimics the human disease","volume":"3","author":"White","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.crmeth.2024.100772_bib29","first-page":"1","article-title":"Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1. Commun","volume":"1","author":"Isakson","year":"2018","journal-title":"Biol."},{"key":"10.1016\/j.crmeth.2024.100772_bib30","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.0000000000005788","article-title":"The biology of cutaneous neurofibromas","volume":"91","author":"Brosseau","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.crmeth.2024.100772_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.crmeth.2024.100772_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2024.100772_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","article-title":"A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids","volume":"2","author":"Phan","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.crmeth.2024.100772_bib34","article-title":"The landscape of drug sensitivity and resistance in sarcoma","author":"Al Shihabi","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.crmeth.2024.100772_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl3674","article-title":"Personalized chordoma organoids for drug discovery studies","volume":"8","author":"Al Shihabi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.crmeth.2024.100772_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100056","article-title":"Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening","volume":"1","author":"Nguyen","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.crmeth.2024.100772_bib37","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/s41467-023-38832-8","article-title":"Drug screening at single-organoid resolution via bioprinting and interferometry","volume":"14","author":"Tebon","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2024.100772_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00401-012-0954-z","article-title":"Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems","volume":"123","author":"Rodriguez","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.crmeth.2024.100772_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.crmeth.2024.100772_bib40","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","article-title":"Cutaneous neurofibromas: Current clinical and pathologic issues","volume":"91","author":"Ortonne","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.crmeth.2024.100772_bib41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s004390100514","article-title":"Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations","volume":"108","author":"Serra","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib42","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.3390\/cancers13122963","article-title":"Severe Phenotype in Patients with Large Deletions of NF1","volume":"13","author":"Pacot","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.crmeth.2024.100772_bib43","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.crmeth.2024.100772_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/humu.21387","article-title":"Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH","volume":"32","author":"Garcia-Linares","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.crmeth.2024.100772_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10048-010-0240-y","article-title":"Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden","volume":"11","author":"Thomas","year":"2010","journal-title":"Neurogenetics"},{"key":"10.1016\/j.crmeth.2024.100772_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ejhg.2011.207","article-title":"Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas","volume":"20","author":"Thomas","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.20389","article-title":"Comprehensive NF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"Maertens","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.crmeth.2024.100772_bib48","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib49","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2014.210","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient","volume":"23","author":"Emmerich","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s10038-008-0320-0","article-title":"Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome","volume":"53","author":"Narumi","year":"2008","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.122.001431","article-title":"Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage","volume":"385","author":"Jackson","year":"2023","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.crmeth.2024.100772_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.crmeth.2024.100772_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2024.100772_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.MP.0000062654.83617.B7","article-title":"Immunohistochemical demonstration of EMA\/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors","volume":"16","author":"Hirose","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.crmeth.2024.100772_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","article-title":"Mast cells and the neurofibroma microenvironment","volume":"116","author":"Staser","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.crmeth.2024.100772_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-019-0317-x","article-title":"Engaging a community to enable disease-centric data sharing with the NF Data Portal","volume":"6","author":"Allaway","year":"2019","journal-title":"Sci. Data"},{"key":"10.1016\/j.crmeth.2024.100772_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.crmeth.2024.100772_bib58","first-page":"1319","article-title":"Cutaneous neurofibroma cells with active YAP promotes proliferation of macrophages resulting in increased accumulation of macrophages by modulating CCL5 and TGF-\u03b21","volume":"43","author":"Jia","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.crmeth.2024.100772_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-012-1056-7","article-title":"Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition","volume":"125","author":"Prada","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.crmeth.2024.100772_bib60","first-page":"411","article-title":"Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633\u00a0nm Red Light Illumination. Photobiomodulation Photomed","volume":"39","author":"Quirk","year":"2021","journal-title":"Laser Surg"},{"key":"10.1016\/j.crmeth.2024.100772_bib61","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014647","article-title":"The matrisome: in\u00a0silico definition and in\u00a0vivo characterization by proteomics of normal and tumor extracellular matrices","volume":"11","author":"Naba","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.crmeth.2024.100772_bib62","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2024.100772_bib63","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcmgh.2022.08.008","article-title":"Culture-Associated DNA Methylation Changes Impact on Cellular Function of Human Intestinal Organoids","volume":"14","author":"Edgar","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.crmeth.2024.100772_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1474-9726.2009.00535.x","article-title":"DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells","volume":"9","author":"Bork","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.crmeth.2024.100772_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128814","article-title":"Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes","volume":"10","author":"Thompson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crmeth.2024.100772_bib66","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-14-0725","article-title":"Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward?","volume":"74","author":"Hatzis","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.crmeth.2024.100772_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113440","article-title":"Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer","volume":"153","author":"Urbaniak","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.crmeth.2024.100772_bib68","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S2352-3026(17)30208-9","article-title":"Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study","volume":"4","author":"Snijder","year":"2017","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.crmeth.2024.100772_bib69","series-title":"Heat Shock Protein-Based Therapies Heat Shock Proteins","first-page":"257","article-title":"Potential of HSP90 Inhibitors to Treat Neurofibromatosis-Related Tumors","author":"Vitte","year":"2015"},{"key":"10.1016\/j.crmeth.2024.100772_bib70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccr.2011.08.014","article-title":"Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors","volume":"20","author":"De Raedt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2024.100772_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5784876","article-title":"Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I\/II Study of Sirolimus in Combination with Ganetespib (SARC023)","volume":"2020","author":"Kim","year":"2020","journal-title":"Sarcoma"},{"key":"10.1016\/j.crmeth.2024.100772_bib72","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.crmeth.2024.100772_bib73","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","article-title":"A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data","volume":"27","author":"Li","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.crmeth.2024.100772_bib74","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.crmeth.2024.100772_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.crmeth.2024.100772_bib76","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.crmeth.2024.100772_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12859-019-2610-2","article-title":"BPG: Seamless, automated and interactive visualization of scientific data","volume":"20","author":"P\u2019ng","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.crmeth.2024.100772_bib78","unstructured":"Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"10.1016\/j.crmeth.2024.100772_bib79","series-title":"Fastqcr: Quality Control of Sequencing Data","author":"Kassambara","year":"2019"},{"key":"10.1016\/j.crmeth.2024.100772_bib80","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/cmb.2014.0029","article-title":"Joint Variant and De Novo Mutation Identification on Pedigrees from High-Throughput Sequencing Data","volume":"21","author":"Cleary","year":"2014","journal-title":"J.\u00a0Comput. Biol."},{"key":"10.1016\/j.crmeth.2024.100772_bib81","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.crmeth.2024.100772_bib82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.crmeth.2024.100772_bib83","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2024.100772_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab033","article-title":"BiSulfite Bolt: A bisulfite sequencing analysis platform","volume":"10","author":"Farrell","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.crmeth.2024.100772_bib85","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1101\/gr.196394.115","article-title":"metilene: fast and sensitive calling of differentially methylated regions from bisulfite sequencing data","volume":"26","author":"J\u00fchling","year":"2016","journal-title":"Genome Res."}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237524001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237524001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T10:42:24Z","timestamp":1716201744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237524001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2667237524001164"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2024.100772","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.07.515469","asserted-by":"object"}]},"ISSN":["2667-2375"],"issn-type":[{"value":"2667-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2024.100772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100772"}}